CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464900. A total of 4 filers reported holding CLOVIS ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $736,000 | -39.9% | 618,600 | -9.1% | 0.00% | -50.0% |
| Q2 2022 | $1,225,000 | +67.6% | 680,500 | +88.1% | 0.00% | +100.0% |
| Q1 2022 | $731,000 | +26.0% | 361,800 | +69.1% | 0.00% | – |
| Q4 2021 | $580,000 | -20.7% | 214,000 | +30.5% | 0.00% | -100.0% |
| Q3 2021 | $731,000 | -58.3% | 164,000 | -45.8% | 0.00% | -50.0% |
| Q2 2021 | $1,755,000 | +27.6% | 302,600 | +54.5% | 0.00% | 0.0% |
| Q1 2021 | $1,375,000 | -73.5% | 195,900 | -81.9% | 0.00% | -77.8% |
| Q4 2020 | $5,181,000 | +32.1% | 1,079,400 | +60.4% | 0.01% | -25.0% |
| Q3 2020 | $3,922,000 | -44.2% | 672,800 | -35.4% | 0.01% | -62.5% |
| Q2 2020 | $7,031,000 | -32.3% | 1,041,700 | -36.2% | 0.03% | -61.9% |
| Q1 2020 | $10,392,000 | -60.8% | 1,634,000 | -35.7% | 0.08% | -53.3% |
| Q4 2019 | $26,505,000 | +766.7% | 2,542,400 | +226.7% | 0.18% | +620.0% |
| Q3 2019 | $3,058,000 | +46.8% | 778,200 | +455.5% | 0.02% | +31.6% |
| Q2 2019 | $2,083,000 | -41.0% | 140,100 | -1.5% | 0.02% | -51.3% |
| Q1 2019 | $3,532,000 | +90.7% | 142,300 | +38.0% | 0.04% | +143.8% |
| Q4 2018 | $1,852,000 | -40.3% | 103,100 | -2.4% | 0.02% | -36.0% |
| Q3 2018 | $3,101,000 | +2.5% | 105,600 | +58.8% | 0.02% | -3.8% |
| Q2 2018 | $3,024,000 | +6.9% | 66,500 | +24.1% | 0.03% | -7.1% |
| Q1 2018 | $2,830,000 | -52.5% | 53,600 | -38.9% | 0.03% | -33.3% |
| Q4 2017 | $5,964,000 | -31.5% | 87,700 | -17.0% | 0.04% | -46.8% |
| Q3 2017 | $8,710,000 | -33.5% | 105,700 | -24.4% | 0.08% | -41.9% |
| Q2 2017 | $13,089,000 | -2.7% | 139,800 | -33.8% | 0.14% | -13.4% |
| Q1 2017 | $13,453,000 | +295.9% | 211,300 | +176.2% | 0.16% | +375.8% |
| Q4 2016 | $3,398,000 | +9.0% | 76,500 | -11.6% | 0.03% | -2.9% |
| Q3 2016 | $3,118,000 | +84.6% | 86,500 | -29.7% | 0.03% | +70.0% |
| Q2 2016 | $1,689,000 | -42.8% | 123,100 | -20.0% | 0.02% | -52.4% |
| Q1 2016 | $2,955,000 | -37.2% | 153,900 | +14.4% | 0.04% | -25.0% |
| Q4 2015 | $4,708,000 | -35.8% | 134,500 | +68.5% | 0.06% | -44.6% |
| Q3 2015 | $7,338,000 | +25.2% | 79,800 | +19.6% | 0.10% | +23.2% |
| Q2 2015 | $5,862,000 | +126.2% | 66,700 | +91.1% | 0.08% | +100.0% |
| Q1 2015 | $2,591,000 | +28.9% | 34,900 | -2.8% | 0.04% | +36.7% |
| Q4 2014 | $2,010,000 | -33.3% | 35,900 | -45.9% | 0.03% | -34.8% |
| Q3 2014 | $3,012,000 | +987.4% | 66,400 | +891.0% | 0.05% | +1050.0% |
| Q2 2014 | $277,000 | -2.5% | 6,700 | +63.4% | 0.00% | -20.0% |
| Q1 2014 | $284,000 | -70.5% | 4,100 | -74.4% | 0.01% | -66.7% |
| Q4 2013 | $964,000 | +44.1% | 16,000 | +45.5% | 0.02% | +15.4% |
| Q3 2013 | $669,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 79,800 | $7,338,000 | 0.10% |
| SIMPLEX TRADING, LLC | 112 | $133,000 | 0.01% |
| Focused Wealth Management, Inc | 1,300 | $12,000 | 0.01% |
| Citadel Advisors | 19,200 | $1,766,000 | 0.00% |